These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31905374)

  • 41. Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis.
    Karale UB; Krishna VS; Krishna EV; Choudhari AS; Shukla M; Gaikwad VR; Mahizhaveni B; Chopra S; Misra S; Sarkar D; Sriram D; Dusthackeer VNA; Rode HB
    Eur J Med Chem; 2019 Sep; 178():315-328. PubMed ID: 31195172
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis.
    Urban M; Šlachtová V; Brulíková L
    Eur J Med Chem; 2021 Feb; 212():113139. PubMed ID: 33422979
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthesis and antimycobacterial activity of imidazo[1,2-b][1,2,4,5]tetrazines.
    Maslov DA; Korotina AV; Shur KV; Vatlin AA; Bekker OB; Tolshchina SG; Ishmetova RI; Ignatenko NK; Rusinov GL; Charushin VN; Danilenko VN
    Eur J Med Chem; 2019 Sep; 178():39-47. PubMed ID: 31176094
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
    Ramprasad J; Nayak N; Dalimba U; Yogeeswari P; Sriram D; Peethambar SK; Achur R; Kumar HS
    Eur J Med Chem; 2015 May; 95():49-63. PubMed ID: 25794789
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis.
    Upton AM; Cho S; Yang TJ; Kim Y; Wang Y; Lu Y; Wang B; Xu J; Mdluli K; Ma Z; Franzblau SG
    Antimicrob Agents Chemother; 2015 Jan; 59(1):136-44. PubMed ID: 25331696
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis and antitubercular evaluation of 4-carbonyl piperazine substituted 1,3-benzothiazin-4-one derivatives.
    Peng CT; Gao C; Wang NY; You XY; Zhang LD; Zhu YX; Xv Y; Zuo WQ; Ran K; Deng HX; Lei Q; Xiao KJ; Yu LT
    Bioorg Med Chem Lett; 2015 Apr; 25(7):1373-6. PubMed ID: 25754492
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 2-N-Arylthiazole inhibitors of Mycobacterium tuberculosis.
    Clark MP; Wang T; Perola E; Deininger DD; Zuccola HJ; Jones SM; Gao H; VanderVen BC; Russell DG; Shoen CM; Cynamon MH; Thomson JA; Locher CP
    Bioorg Med Chem Lett; 2017 Sep; 27(17):3987-3991. PubMed ID: 28778468
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates.
    Ribeiro RCB; de Marins DB; Di Leo I; da Silva Gomes L; de Moraes MG; Abbadi BL; Villela AD; da Silva WF; da Silva LCRP; Machado P; Bizarro CV; Basso LA; Cristina de Moraes M; Ferreira VF; da Silva FC; Nascimento V
    Eur J Med Chem; 2021 Jan; 209():112859. PubMed ID: 33010635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Discovery of thienothiazolocarboxamide analogues as novel anti-tubercular agent.
    Jin G; Mi Kim Y; Lee A; Choi J; Kang S; Seo M; Jea Seo J; Lee S; Kang J; Kim J; Park S; Woo M; Falcão VCA; Lee H; Heo J; Shum D; Park K; Delorme V; Choi I
    Bioorg Med Chem; 2020 Dec; 28(23):115797. PubMed ID: 33075682
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 6-Nitro-2,3-dihydroimidazo[2,1-b][1,3]thiazoles: Facile synthesis and comparative appraisal against tuberculosis and neglected tropical diseases.
    Thompson AM; Blaser A; Palmer BD; Anderson RF; Shinde SS; Launay D; Chatelain E; Maes L; Franzblau SG; Wan B; Wang Y; Ma Z; Denny WA
    Bioorg Med Chem Lett; 2017 Jun; 27(11):2583-2589. PubMed ID: 28462832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acetylene containing cyclo(L-Tyr-L-Tyr)-analogs as mechanism-based inhibitors of CYP121A1 from Mycobacterium tuberculosis.
    Ortega Ugalde S; Wallraven K; Speer A; Bitter W; Grossmann TN; Commandeur JNM
    Biochem Pharmacol; 2020 Jul; 177():113938. PubMed ID: 32224137
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Design, synthesis, and biological evaluation of novel imidazo[1,2-a]pyridinecarboxamides as potent anti-tuberculosis agents.
    Onajole OK; Lun S; Yun YJ; Langue DY; Jaskula-Dybka M; Flores A; Frazier E; Scurry AC; Zavala A; Arreola KR; Pierzchalski B; Ayitou AJ; Bishai WR
    Chem Biol Drug Des; 2020 Dec; 96(6):1362-1371. PubMed ID: 32515129
    [TBL] [Abstract][Full Text] [Related]  

  • 53. 8-Hydroxyquinolines are bactericidal against Mycobacterium tuberculosis.
    Odingo JO; Early JV; Smith J; Johnson J; Bailey MA; Files M; Guzman J; Ollinger J; Korkegian A; Kumar A; Ovechkina Y; Parish T
    Drug Dev Res; 2019 Aug; 80(5):566-572. PubMed ID: 30893501
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives.
    Wang H; Wang A; Gu J; Fu L; Lv K; Ma C; Tao Z; Wang B; Liu M; Guo H; Lu Y
    Eur J Med Chem; 2019 Mar; 165():11-17. PubMed ID: 30654236
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis and antitubercular evaluation of novel dibenzo[b,d]thiophene tethered imidazo[1,2-a]pyridine-3-carboxamides.
    Pulipati L; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
    Bioorg Med Chem Lett; 2016 Jul; 26(13):3135-3140. PubMed ID: 27184765
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
    Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
    ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Imidazopyridine Compounds Inhibit Mycobacterial Growth by Depleting ATP Levels.
    O'Malley T; Alling T; Early JV; Wescott HA; Kumar A; Moraski GC; Miller MJ; Masquelin T; Hipskind PA; Parish T
    Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632008
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines.
    Protopopova M; Hanrahan C; Nikonenko B; Samala R; Chen P; Gearhart J; Einck L; Nacy CA
    J Antimicrob Chemother; 2005 Nov; 56(5):968-74. PubMed ID: 16172107
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Telacebec (Q203): Is there a novel effective and safe anti-tuberculosis drug on the horizon?
    Malík I; Čižmárik J; Kováč G; Pecháčová M; Hudecova L
    Ceska Slov Farm; 2021; 70(5):164–171. PubMed ID: 34875838
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Indole-2-carboxamide-based MmpL3 Inhibitors Show Exceptional Antitubercular Activity in an Animal Model of Tuberculosis Infection.
    Stec J; Onajole OK; Lun S; Guo H; Merenbloom B; Vistoli G; Bishai WR; Kozikowski AP
    J Med Chem; 2016 Jul; 59(13):6232-47. PubMed ID: 27275668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.